Birch Financial Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,471
Closed -$275K 143
2026
Q1
$275K Sell
7,471
-813
-10% -$38.5K 0.16% 105
2025
Q4
$421K Sell
8,284
-8,538
-51% -$437K 0.24% 79
2025
Q3
$933K Buy
16,822
+1,957
+13% +$115K 0.55% 41
2025
Q2
$1.03M Buy
14,865
+3,488
+31% +$237K 0.82% 27
2025
Q1
$790K Buy
11,377
+4,888
+75% +$404K 0.7% 31
2024
Q4
$558K Buy
+6,489
New +$702K 0.63% 31

Other funds holding NVO

Birch Financial Group's NVO Position: Q2 2026 in Review

Birch Financial Group sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 7,471 shares — an estimated $275K sold.

Birch Financial Group first reported a position in NVO in Q4 2024 and held it in 6 quarters. The position peaked at $1.03M in Q2 2025. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Birch Financial Group reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Birch Financial Group sold 7,471 Novo Nordisk shares in Q2 2026, an estimated $275K.
  • Birch Financial Group first reported a position in Novo Nordisk in Q4 2024 and held it in 6 quarters.
  • Birch Financial Group's Novo Nordisk position peaked at $1.03M in Q2 2025.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Birch Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.